Treatment of pancreatic adenocarcinoma with the combinationof carboplatin and velparib

Phase 1

• Conditions: pancreatic adenocarcinoma; MedDRA version: 17.0Level: LLTClassification code 10033611Term: Pancreatic carcinoma non-resectableSystem Organ Class: 100000004864; Therapeutic area: Diseases [C] - Cancer [C04]

• Registration Number: EUCTR2014-003785-24-HU
• Lead Sponsor: zsoki Utcai Kórház

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-09-12
• Last Update Posted: 9 January 2017

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

inoperable pancretaic adenocarcinoma with ATM-P604S mutation
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

operable pancreas tumor at the screening CT

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified